Setting the Record Straight on Ivermectin
SHARE | PRINT | EMAIL
Ivermectin has a distinguished history, and it may have benefits comparable to those of penicillin. The anti-parasitic’s discovery led to a Nobel Prize and su... Read more.
Charles L. Hooper is President and co-founder of Objective Insights, Inc. Prior to forming Objective Insights in 1994, Charley worked at Merck & Co., Syntex Labs, and NASA. Charley’s experience is in decision analysis, economics, product pricing, forecasting, and modeling. He is passionate about helping pharmaceutical companies think clearly about their business opportunities.